SIGHINOLFI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.004
AS - Asia 1.086
EU - Europa 849
SA - Sud America 170
AF - Africa 47
OC - Oceania 9
Totale 4.165
Nazione #
US - Stati Uniti d'America 1.941
SG - Singapore 422
CN - Cina 213
GB - Regno Unito 151
FI - Finlandia 145
HK - Hong Kong 144
BR - Brasile 131
IT - Italia 122
VN - Vietnam 120
SE - Svezia 115
DE - Germania 102
RU - Federazione Russa 55
FR - Francia 42
IN - India 37
MX - Messico 27
CA - Canada 26
KR - Corea 25
ID - Indonesia 20
ZA - Sudafrica 19
AR - Argentina 17
BD - Bangladesh 17
PL - Polonia 15
IQ - Iraq 13
BG - Bulgaria 12
UA - Ucraina 11
LT - Lituania 10
SI - Slovenia 10
AT - Austria 9
JP - Giappone 9
PK - Pakistan 9
UZ - Uzbekistan 9
AU - Australia 8
DK - Danimarca 8
ES - Italia 8
MA - Marocco 8
MY - Malesia 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
KE - Kenya 6
CL - Cile 5
CO - Colombia 5
IR - Iran 5
PH - Filippine 5
VE - Venezuela 5
JO - Giordania 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
BY - Bielorussia 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.165
Città #
Ashburn 311
Singapore 291
Santa Clara 226
Chandler 169
Hong Kong 143
Fairfield 141
Helsinki 127
San Jose 97
Nyköping 76
London 61
Houston 58
Woodbridge 53
Seattle 45
The Dalles 43
Los Angeles 41
Southend 39
Council Bluffs 37
Munich 37
Wilmington 37
Cambridge 36
New York 35
Beijing 34
Ho Chi Minh City 31
Hefei 27
Hanoi 25
Modena 25
Seoul 25
Chicago 24
San Diego 21
Princeton 18
Shanghai 18
Bremen 17
Dallas 17
Lauterbourg 17
Turku 17
Ann Arbor 16
Jakarta 16
Johannesburg 16
Fremont 15
Da Nang 14
Jacksonville 14
Brooklyn 12
Sofia 12
São Paulo 12
Moscow 11
Orem 11
Portsmouth 11
Warsaw 11
Atlanta 10
Chennai 9
Mexico City 9
Parma 9
Baghdad 8
Buffalo 8
Dearborn 8
Mumbai 8
Toronto 8
Frankfurt am Main 7
Nuremberg 7
Stockholm 7
Sydney 7
Tokyo 7
Denver 6
Genoa 6
Milan 6
Montreal 6
Nairobi 6
Ottawa 6
Phoenix 6
Poplar 6
Redondo Beach 6
Rio de Janeiro 6
Rome 6
Salt Lake City 6
Tashkent 6
Amsterdam 5
Manchester 5
Amman 4
Birmingham 4
Biên Hòa 4
Bologna 4
Changsha 4
Dong Ket 4
Düsseldorf 4
Ghent 4
Haiphong 4
Querétaro 4
San Mateo 4
Secaucus 4
Belo Horizonte 3
Bexley 3
Boardman 3
Brussels 3
Bucharest 3
City of London 3
Dhaka 3
Guangzhou 3
Ha Long 3
Hillsboro 3
Istanbul 3
Totale 2.871
Nome #
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay. 337
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 325
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 276
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 268
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 260
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 259
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 255
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 244
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 241
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 224
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 203
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 196
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 189
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 187
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 182
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 165
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 164
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 146
Tossicità in vitro di nanoparticelle metalliche in linee e colture cellulari neuronali 70
Totale 4.191
Categoria #
all - tutte 18.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 25 43 8
2021/2022255 18 12 9 5 13 12 8 13 42 12 51 60
2022/2023475 69 67 36 41 58 50 14 52 41 0 19 28
2023/2024281 8 16 24 36 53 34 25 32 4 10 15 24
2024/2025917 25 10 13 79 149 139 84 41 129 43 66 139
2025/20261.774 133 74 127 232 336 166 273 83 170 180 0 0
Totale 4.191